DXC Technology DXC yesterday announced that it has agreed to sell its healthcare software provider business unit to privately-held Dedalus Group for a total cash consideration of $525 million. The transaction is anticipated to complete by March 2021.
DXC’s innovative healthcare software give clinicians and caregivers the tools they need to improve processes across the continuum of care. The company’s technology solutions provide tools to healthcare providers to better connect with their patients, which helps them boost productivity and patient outcomes.
The latest divestment can be seen as part of DXC’s strategy to offload non-core assets. Notably, the IT and consulting services provider announced last November that it is exploring options to divest three of its non-core businesses, including the State and Local HHS business, the horizontal BPS business and the workplace and mobility business. The three units account for about 25% of DXC’s total revenues, on a combined basis.